Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19985075 | 0.89 | CA12 (0.30) | CA12CA1CA9 | |
| SCHEMBL15605734 | 0.81 | CA12 (0.34) | CA12CA1CA9DNM1TSHR | |
| SCHEMBL20130839 | 0.79 | CA12 (0.33) | CA12CA1CA9 | |
| SCHEMBL15605797 | 0.77 | ADRB2 (0.35) | CA12CA1CA9TSHRALDH1A1 | |
| SCHEMBL15605738 | 0.77 | CA12 (0.32) | CA12CA1CA9 | |
| SCHEMBL15605732 | 0.77 | CA12 (0.32) | CA12CA1CA9 | |
| SCHEMBL20130873 | 0.75 | CA12 (0.31) | CA12CA1CA9 | |
| SCHEMBL20130863 | 0.75 | CA12 (0.31) | CA12CA1CA9 | |
| SCHEMBL2549420 | 0.73 | CA12 (0.40) | CA12CA1CA9DNM1TSHR | |
| SCHEMBL10713784 | 0.72 | DNM1 (0.44) | CA12CA1CA9DNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10703915-B2 | Compositions and methods for the deposition of silicon oxide films | VERSUM MATERIALS US, LLC (US) | 2020-07-07 | — | — | US | disclosed |
| US-20200040192-A9 | Compositions and Methods for the Deposition of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2020-02-06 | — | — | US | disclosed |
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | CA12 62/4885CA1 42/4885CA9 130/4885 |
| US-20200040192-A9 | Compositions and Methods for the Deposition of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | CA12 62/4885CA1 42/4885CA9 130/4885 |
| US-10703915-B2 | Compositions and methods for the deposition of silicon oxide films | SEPTIN9, SGMS1, SGMS2 | CA12 62/4885CA1 42/4885CA9 130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.